2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$9.92-$0.06 (-0.64%)
Price as of Nov 12, 2026 8:10 AM EST- $1.6BMarket Cap
- 38.61%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$9.92-$0.06 (-0.64%)
NVAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.98 | ||
Change | -$0.22 (-2.16%) | ||
Open | $10.28 | ||
High | $10.36 | ||
Low | $9.89 | ||
Previous Close | $10.20 | ||
Volume | 5,895,990 | ||
30-Day Average Volume | 6,764,454 | ||
1-Week Change | -6.29% | ||
1-Month Change | -21.73% | ||
1-Year Change | 38.61% | ||
3-Year Change | 59.94% | ||
5-Year Change | -94.11% | ||
Fundamentals | |||
Shares Outstanding | 165.0M | ||
Total Assets | $888.0M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $25.7M | ||
Net Income | -$31.4M | ||
Free Cash Flow | -$95.3M | ||
EBIT | -$25.1M | ||
EBITDA | -$22.0M | ||
Net Working Capital | $378.1M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -78 | ||
Enterprise Value/Revenue | 67 | ||
P/B | -8 | ||
P/E | -53 | ||
PEG | -1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/13/2007 | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 05/10/2019 | ||
Earnings & Revenue